相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms
Suresh Banjara et al.
BIOMOLECULES (2020)
Pyrrolo[2′,3′:3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types
Virginia Spano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review
Eavan C. McLoughlin et al.
PHARMACEUTICALS (2020)
Microtubules in cell migration
Clare Garcin et al.
MECHANISMS OF CELL MIGRATION (2019)
Recent advances in microtubule-stabilizing agents
Ya-Nan Cao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Sea Urchin Embryo Model As a Reliable in Vivo Phenotypic Screen to Characterize Selective Antimitotic Molecules. Comparative evaluation of Combretapyrazoles, -isoxazoles,-1,2,3-triazoles, and -pyrroles as Tubulin-Binding Agents
Marina N. Semenova et al.
ACS COMBINATORIAL SCIENCE (2018)
Choline Kinase Alpha Inhibition by EB-3D Triggers Cellular Senescence, Reduces Tumor Growth and Metastatic Dissemination in Breast Cancer
Elena Mariotto et al.
CANCERS (2018)
Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures
Wenlong Li et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Microtubule organization, dynamics and functions in differentiated cells
Andrew Muroyama et al.
DEVELOPMENT (2017)
Inhibitor of apoptosis proteins as intracellular signaling intermediates
Andrew J. Kocab et al.
FEBS JOURNAL (2016)
Synthesis and biological activity of pyrrole analogues of combretastatin A-4
Eun-Kyung Jung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth
Maria Jesus Perez-Perez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Recent Advancement in Discovery and Development of Natural Product Combretastatin-inspired Anticancer Agents
Pravin O. Patil et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2015)
Natural antitubulin agents: Importance of 3,4,5-trimethoxyphenyl fragment
Arvind S. Negi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Synthesis and Biological Evaluations of 1,2-Diaryl Pyrroles as Analogues of Combretastatin A-4
Jun Sun et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
Design, Synthesis, in Vitro, and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylaminobenzofuran Derivatives Targeting the Colchicine Site on Tubulin
Romeo Romagnoli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Quantum Chemistry Calculation-Aided Structural Optimization of Combretastatin A-4-like Tubulin Polymerization Inhibitors: Improved Stability and Biological Activity
Junhang Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A phase I clinical trial assessing the safety and tolerability of combretastatin A4 phosphate injections
Peng Liu et al.
ANTI-CANCER DRUGS (2014)
Poly(ADP-ribose): A signaling molecule in different paradigms of cell death
Francesca Aredia et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Recent advances in vascular disrupting agents in cancer therapy
Elena Porcu et al.
FUTURE MEDICINAL CHEMISTRY (2014)
The Novel Microtubule-Destabilizing Drug BAL27862 Binds to the Colchicine Site of Tubulin with Distinct Effects on Microtubule Organization
Andrea E. Prota et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Design of Combretastatin A-4 Analogs as Tubulin Targeted Vascular Disrupting Agent with Special Emphasis on Their Cis-Restricted Isomers
Harish Rajak et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Concise Synthesis and Biological Evaluation of 2-Aroyl-5-Amino Benzo[b]thiophene Derivatives As a Novel Class of Potent Antimitotic Agents
Romeo Romagnoli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3′,4′,5′-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents
Romeo Romagnoli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Microtubule-targeted agents: When mitochondria become essential to chemotherapy
A. Rovini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2011)
Developments of Combretastatin A-4 Derivatives as Anticancer Agents
Y. Shan et al.
CURRENT MEDICINAL CHEMISTRY (2011)
One-pot synthesis and biological evaluation of 2-pyrrolidinyl-4-amino-5-(3′,4′,5′-trimethoxybenzoyl)thiazole: A unique, highly active antimicrotubule agent
Romeo Romagnoli et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Drugs That Target Dynamic Microtubules: A New Molecular Perspective
Richard A. Stanton et al.
MEDICINAL RESEARCH REVIEWS (2011)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
On and Around Microtubules: An Overview
Richard H. Wade
MOLECULAR BIOTECHNOLOGY (2009)
In vitro and in vivo phase II metabolism of combretastatin A-4: Evidence for the formation of a sulphate conjugate metabolite
S. Aprile et al.
XENOBIOTICA (2009)
In Vivo Roles of CDC25 Phosphatases: Biological Insight into the Anti-Cancer Therapeutic Targets
Hiroaki Kiyokawa et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
In vitro metabolism study of combretastatin A-4 in rat and human liver Microsomes
Silvio Aprile et al.
DRUG METABOLISM AND DISPOSITION (2007)
Combretastatin a-4 analogs as anticancer agents
Anurag Chaudhary et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2007)
4,5-Diaryl-1H-pyrrole-2-carboxylates as combretastatin A-4/lamellarin T hybrids:: Synthesis and evaluation as anti-mitotic and cytotoxic agents
MG Banwell et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling
L Vincent et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Phase I trial of combretastatin A-4 phosphate with carboplatin
JH Bilenker et al.
CLINICAL CANCER RESEARCH (2005)
Review: Tubulin function, action of antitubulin drugs, and new drug development
F Pellegrini et al.
CANCER INVESTIGATION (2005)
Pharmaceutical design of antimitotic agents based on combretastatins
HP Hsieh et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Combretastatin A-4 analogues as antimitotic antitumor agents
NH Nam
CURRENT MEDICINAL CHEMISTRY (2003)
Structural requirements for the interaction of combretastatins with tubulin: how important is the trimethoxy unit?
K Gaukroger et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2003)
Design, synthesis and cytotoxic activities of naphthyl analogues of combretastatin A-4
ABS Maya et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
分享论文
